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ABSTRACT Band 4.2 is a human erythrocyte membrane protein of incompletely characterized structure and function.
Erythrocytes deficient in band 4.2 protein were used to examine the functional role of band 4.2 in intact erythrocyte
membranes. Both the lateral and the rotational mobilities of band 3 were increased in band 4.2-deficient erythrocytes
compared to control cells. In contrast, the lateral mobility of neither glycophorins nor a fluorescent phospholipid analog was
altered in band 4.2-deficient cells. Compared to controls, band 4.2-deficient erythrocytes manifested a decreased ratio of
band 3 to spectrin, and band 4.2-deficient membrane skeletons had decreased extractability of band 3 under low-salt
conditions. Normal band 4.2 was found to bind to spectrin in solution and to promote the binding of spectrin to ankyrin-
stripped inside-out vesicles. We conclude that band 4.2 provides low-affinity binding sites for both band 3 oligomers and
spectrin dimers on the human erythrocyte membrane. Band 4.2 may serve as an accessory linking protein between the
membrane skeleton and the overlying lipid bilayer.
INTRODUCTION
Human erythrocyte band 4.2 is a 72-kDa protein that is
bound to the inner membrane surface through interactions
with the band 3 (anion channel) protein. Each normal eryth-
rocyte contains approximately 250,000 band 4.2 molecules
(reviewed in Cohen et al., 1993). Although the exact func-
tion of band 4.2 is not known, several examples of hemo-
lytic anemia associated with band 4.2 deficiency demon-
strate that the protein is essential for normal erythrocyte
survival and function (see Cohen et al., 1993; Yawata, 1994,
for reviews). Erythrocytes lacking or deficient in band 4.2
have a shortened lifespan and have shape abnormalities
ranging from mild to pronounced spherocytosis or ovalocy-
tosis (Yawata, 1994). Band 4.2 deficiency has been associ-
ated with both defects in the cytoplasmic domain of the
band 3 protein (Jarolim et al., 1992; Rybicki et al., 1993)
and mutations in the band 4.2 gene itself (Bouhassira et al.,
1992; Hayette et al., 1995a,b; Iwamoto et al., 1993; Kanzaki
et al., 1995a,b; Takaoka et al., 1994). In the latter cases
membrane-associated band 4.2 is completely absent by
Coomassie blue staining of sodium dodecyl sulfate (SDS)
gels, although in some cases small amounts of 72 and 74
kDa immunoreactive species can be detected by Western
blotting (reviewed in Cohen et al., 1993; Yawata, 1994).
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The detrimental changes in the shape and survival of band
4.2-deficient erythrocytes suggest that band 4.2 may play an
important role in membrane skeletal function. Electron micro-
scopic analysis indicates that band 4.2 may have a direct effect
on the organization of the skeletal network (Inoue et al., 1994).
The band 4.2 protein does not behave like a typical membrane
skeletal protein, however. Unlike other skeletal proteins, band
4.2 is readily extracted from erythrocyte membranes by the
non-ionic detergent Triton X-100 (Korsgren and Cohen, 1986;
Steck and Yu, 1973; Yu et al., 1973). Band 4.2 is retained on
membranes from which all other membrane skeletal proteins
have been eluted (Korsgren and Cohen, 1986; Steck and Yu,
1973; Yu et al., 1973). It has been suggested that band 4.2 may
be involved in the stabilization of ankyrin binding to the inner
surface of the erythrocyte membrane (Rybicki et al., 1988), but
this has not been confirmed in other studies (Ideguchi et al.,
1990; Korsgren and Cohen, 1988). Band 4.2 does bind to the
cytoplasmic domain of band 3, which serves as a crucial
anchorage site for several membrane-skeleton interactions. It is
therefore possible that band 4.2 plays a role in promoting or
stabilizing membrane-skeleton linkages. Here, we provide ev-
idence that band 4.2 is involved in linking band 3 oligomers to
the membrane skeleton, possibly through direct associations
between band 4.2 and spectrin. Our results suggest that band
4.2 may be one of several proteins that stabilize linkages
between the membrane skeleton and the erythrocyte mem-
brane.
MATERIALS AND METHODS
Eosin maleimide was purchased from Molecular Probes (Eugene, OR).
Glucose oxidase and catalase were obtained from Sigma Chemical Co. (St.
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Louis, MO). Fresh blood was collected by venipuncture, anticoagulated
with acid/citrate/dextrose, and shipped on ice to Boston by overnight
courier. Within 48 h of venipuncture the buffy coat was removed by
aspiration, and erythrocytes were washed three times and stored at 4°C in
high potassium phosphate-buffered saline (KPBS) (140 mM KCI, 15 mM
NaPO4, 10 mM glucose, pH 7.4). High potassium buffers were used to
prevent possible cellular dehydration associated with deoxygenation and
fluorescent labeling.
Specific fluorescent labeling of erythrocyte
band 3
One hundred microliters of freshly washed packed erythrocytes was incu-
bated with 40 ,ul of eosin maleimide, 0.25 mg/ml in KPBS, at room
temperature for 12 min. Cells were then washed three times in KPBS with
1% bovine serum albumin (BSA). Under these labeling conditions >80%
of the membrane associated fluorescence was covalently bound to band 3
(Golan, 1989).
Specific fluorescent labeling of
erythrocyte glycophorins
One hundred microliters of freshly washed packed erythrocytes was incu-
bated with 100,ul of NaIO4, 2 mM in KPBS without glucose, at 4°C for 15
min. Cells were then washed twice in KPBS with 0.1 M glycerol and once
with KPBS. One hundred microliters of oxidized erythrocytes was added to
100 ,ul of fluorescein thiosemicarbazide, 0.5 mg/ml in KPBS, at 40C for 1
h. Labeled cells were washed three times in KPBS with 1% BSA. Under
these conditions >80% of the membrane-associated fluorescence was
covalently bound to sialoglycoproteins (glycophorins); of this amount 75%
was bound to glycophorin A (Golan, 1989).
Incorporation of the fluorescent phospholipid
analog fluorescein phosphatidylethanolamine into
intact erythrocyte membranes
Twenty microliters of fluorescein phosphatidylethanolamine (FI-PE), 1
mg/ml in chloroform, was dried, resuspended in 0.5 ml of KPBS, and
sonicated for 20 min in a low-power bath sonicator. One hundred micro-
liters of freshly washed packed erythrocytes was incubated with the Fl-PE
solution at room temperature for 30 min. Cells were then washed three
times in KPBS with 1% BSA.
Lateral mobility measurements
Fluorescence photobleaching recovery (Axelrod et al., 1976) was used to
measure the lateral mobility of band 3, glycophorins, and Fl-PE in mem-
branes of intact erythrocytes. A gaussian laser beam was focused to a spot
on the upper membrane of a labeled erythrocyte in a fluorescence micro-
scope. After a brief, intense photobleaching pulse, recovery of fluorescence
was monitored by periodic low-intensity pulses. Fluorescence recovery
resulted from the lateral diffusion of unbleached fluorophores into the
bleached area. Nonlinear least-squares analysis (Bevington, 1969) of flu-
orescence recovery data yielded both the diffusion coefficient and the
fraction of labeled band 3 molecules that were free to diffuse on the time
scale of the experiment (Golan et al., 1986). The effects of cell shape on
fluorescence recovery kinetics were negligible because intracellular hemo-
globin effectively shielded the lower membrane from excitation laser light
and/or emitted fluorescence (unpublished observations), and because eryth-
rocytes from the two patients used in this study exhibited only a mild
degree of ovalocytosis. Details of the electronics and optics used in our
fluorescence photobleaching recovery apparatus have been published (Cor-
bett and Golan, 1993). All measurements were performed at 37°C. Using
algorithms developed by Yoshida and Barisas (1986), the local temperature
rise during the bleaching pulse because of laser-induced heating of surface
fluorophores was < 0.02°C, and that because of heating of intracellular
hemoglobin was 0.03°C.
Rotational mobility measurements
Polarized fluorescence depletion (PFD) (Yoshida and Barisas, 1986) was
used to measure the rotational mobility of eosin-labeled band 3 in mem-
branes of intact erythrocytes. Eosin molecules were photoselected to the
triplet state by an intense polarized laser pulse. The decay of induced
anisotropy was measured by monitoring ground-state fluorescence oriented
parallel and perpendicular to the photoselection pulse (Johnson and Gar-
land, 1981; Matayoshi and Jovin, 1991; Yoshida and Barisas, 1986). By
using our laser microscope photometer, two exponential components of
anisotropy decay and a residual anisotropy could be resolved, so data were
fitted by nonlinear least-squares analysis to the equation
r(t) = r(oo) + a - exp(-t/ITI) + 3* exp(-t/T2),
where r(t) was the anisotropy at time t, r(oo) was the residual anisotropy,
and a and ,3 were the fractions of molecules with rotational correlation
times T, and T2, respectively. An enzyme oxygen scavenging system,
consisting of 50 units/ml glucose oxidase, 20 mM glucose, and 104
units/ml catalase, served to eliminate oxygen from the sample and thereby
prevent quenching of the excited triplet state of eosin (Johnson and Gar-
land, 1981). Slides were prepared for PFD experiments by placing 3.2 ,u
of a 10% erythrocyte suspension on a BSA-coated glass slide and using
vacuum grease to seal a BSA-coated coverslip over the sample. Details of
the electronics and optics used in our PFD apparatus have been published
(Corbett and Golan, 1993). All measurements were performed at 37°C.
Biochemical analysis of erythrocyte membranes
The spectrin content, band 3 content, spectrin/band 3 ratio, and band 4.2
content of band 4.2-deficient and control erythrocyte membranes were
measured by densitometric scans of Coomassie blue-stained SDS-poly-
acrylamide Laemmli gels (Laemmli, 1970). Quantitative densitometry was
performed using a Stratagene (La Jolla, CA) Eagle Eye II video densitom-
eter and RFLP Scan software (Scanalytics, Billerica, MA).
Extraction of band 3 by Triton X-100
Ghost membranes were prepared from simultaneously drawn band 4.2-
deficient and control erythrocytes, as described (Korsgren and Cohen,
1988). Ghost samples were diluted to 1 mg protein/ml in 5 mM sodium
phosphate, 0.5 mM EGTA, pH 7.6, with or without 150 mM NaCl. Thirty
microliters of dilute ghost sample was added to 30 ,ul Triton X-100 in the
same dilution buffer, such that the final Triton concentration was 0, 0.1,
0.5, or 1% (v/v). Samples were incubated on ice for 30 min and centrifuged
in a Sorvall SS34 rotor at 17,000 rpm for 20 min. The supernatants were
withdrawn and saved. Both the supematants and pellets were solubilized in
gel sample buffer containing 4% SDS and electrophoresed on 9% acryl-
amide gels, according to the method of Laemmli (1970). Coomassie
blue-stained gels of supernatants and pellets were scanned, and the areas
under the band 3 and spectrin/ankyrin peaks were quantitated, as described
above.
Binding of spectrin to band 4.2 in solution
Erythrocyte spectrin and band 4.2 were prepared as previously described
(Cohen and Foley, 1984; Korsgren and Cohen, 1988). Spectrin and band
4.2 were iodinated by using 125I-labeled Bolton-Hunter reagent (DuPont-
New England Nuclear, Boston, MA). Binding of '25I-spectrin to band 4.2
was assayed by immunoprecipitation, performed exactly as described in
Korsgren and Cohen (1988), at a fixed band 4.2 concentration of 4 ,ug/ml.
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Polyclonal rabbit anti-band 4.2 antiserum and Pansorbin (Calbiochem, San
Diego, CA) were used to immunoprecipitate spectrin-band 4.2 complexes.
'25I-Spectrin was incubated in the absence of band 4.2, at spectrin con-
centrations spanning the range used in the binding experiment, to correct
for nonspecific binding of '25I-spectrin. Nonspecific binding was sub-
tracted from total 1251-spectrin binding in the presence of band 4.2. The
amount of band 4.2 protein immunoprecipitated by the polyclonal anti-
serum and Pansorbin was determined by performing a control immuno-
precipitation with '25I-band 4.2 in the absence of spectrin. This control
value was used to normalize the amount of bound spectrin to the amount
of immunoprecipitated band 4.2. Binding data were analyzed using both
Enzfitter (Elsevier Biosoft, Amsterdam, The Netherlands) and TableCurve
for Windows (Jandel, San Rafael, CA) software.
Binding of spectrin to band 4.2
reconstituted membranes
Erythrocyte spectrin and band 4.2 were prepared as described above.
Inside-out vesicles, alkaline (pH 11)-stripped membranes, and band 4.2
reconstituted alkaline-stripped membranes were prepared, and the binding
protocols were performed, according to procedures described in Korsgren
and Cohen (1988). Membranes were reconstituted with band 4.2 by incu-
bating pH 11-stripped membranes (0.25 mg protein/ml) with band 4.2 (0.2
mg protein/ml) for 18 h at 25°C, as described (Korsgren and Cohen, 1988).
The band 4.2 content of the reconstituted membranes was confirmed by
SDS gel electrophoresis. '25I-Spectrin binding to inside-out vesicles, pH
11 -stripped membranes, and band 4.2 reconstituted pH 1 1-stripped mem-
branes was performed by incubating '25I-spectrin with membranes (25 .g
protein/ml) in 300 ,ul of 120 mM KCl, 5 mM sodium phosphate, 0.5 mM
EGTA, 0.5 mM dithiothreitol, 0.02% NaN3, 1 mg/ml BSA, and 10 ,ug/ml
phenylmethylsulfonyl fluoride (pH 7.6) at 4°C for 90 min. Two 100-pLI
aliquots were centrifuged in a 42.2 Ti rotor at 17,000 rpm for 20 min, the
supernatants were carefully removed, and the pellets were counted for 125I.
Added spectrin was determined by counting two 20-,ul aliquots of the
reaction mixture. Control binding incubations were performed at each
spectrin concentration in the absence of membranes, to correct for non-
specific sedimentation of '251-spectrin. Nonspecific sedimentation was
subtracted from total '251-spectrin sedimented in the presence of mem-
branes.
RESULTS
Lateral and rotational mobility
The lateral and rotational mobilities of band 3, glycophor-
ins, and F1-PE were measured in four different experiments
on intact erythrocytes from two patients with a subset of
hereditary spherocytosis in which erythrocytes were com-
pletely deficient in band 4.2 (Ata et al., 1989; Ghanem et al.,
1990). The lateral diffusion coefficient of band 3 in mem-
branes of band 4.2-deficient erythrocytes was approxi-
mately twofold greater than control values. Although we
were able to obtain samples from only two individuals with
band 4.2 deficiency for the present study, there was much
less difference between the diffusion coefficients in the two
band 4.2-deficient erythrocyte samples than there was be-
tween the diffusion coefficients in band 4.2-deficient com-
pared to control cells. The band 3 fractional mobility in
membranes of band 4.2-deficient erythrocytes was not sig-
nificantly different from control values (Fig. 1, Table 1).
Neither the lateral diffusion coefficient nor the fractional
mobility of glycophorins and FI-PE in membranes of band
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FIGURE 1 Typical fluorescence photobleaching recovery curves depict-
ing the lateral mobility of band 3 in intact erythrocytes from patients with
band 4.2 deficiency (HS, *) and controls (Control, 0). Data points repre-
sent fluorescence counts at experimental times before and after the pho-
tobleaching pulse, which occurred at time 0. Band 4.2 deficient erythro-
cytes showed increased lateral diffusion coefficients relative to control
erythrocytes, indicating increased freedom of band 3 lateral movement.
Band 4.2 deficiency, diffusion coefficient = 3.9 x 10-11 cm2 s-1, frac-
tional mobility = 65%. Control, diffusion coefficient = 1.4 x 10-" cm2
s- ', fractional mobility = 58%.
4.2-deficient erythrocytes was significantly different from
control values (Table 2).
Both band 4.2-deficient and control erythrocytes exhib-
ited rapidly rotating, slowly rotating, and rotationally im-
mobile populations of band 3. Compared to control eryth-
rocytes, band 4.2-deficient erythrocytes manifested a
significant shift from the slowly rotating and rotationally
immobile populations of band 3 to the rapidly rotating
TABLE I Lateral mobility of band 3 in band 4.2-deficient and
control erythrocytes
D f
Sample (X 1011 cm2 s-1) (%) n
4.2 (-)-I 4.1 ± 2.3 52 ± 10 31
4.2(-)-2 3.1 ± 1.3 63 ±7 9
4.2 (-)-mean 3.8 + 2.2* 55 ± Ilt 40
Control-i 2.0 ± 1.2 57 ± 12 31
Control-2 1.5 ± 0.7 53 ± 10 9
Control-mean 1.9 ± 1.2* 56 ± 121 40
Fluorescence photobleaching recovery was used to measure the lateral
mobility of eosin labeled band 3 in intact erythrocytes from two patients
with band 4.2 deficiency and hereditary spherocytosis and two controls
with normal erythrocyte morphology. Experiments were performed at
37°C. D, diffusion coefficient; f, fractional mobility; n, number of mea-
surements. Values represent mean ± standard deviation. The significance
of differences between means for band 4.2-deficient and control samples
was tested by using Student's unpaired two-tailed t-test (StatVeiw 512+,
Abacus Concepts, Berkeley, CA). Values for control erythrocytes were
statistically identical to results in a population of approximately 35 control
individuals (see Corbett and Golan, 1993; Corbett et al., 1994).
p= 0.0001.
tp = 0.59.
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TABLE 2 Lateral mobility of glycophorins and FI-PE in band
4.2-deficient and control erythrocytes
D f
Sample (X 101l cm2 s-1) (%) n
4.2 (-)-1/GP 3.5 ± 1.0* 44 ± 8t 11
Control-1/GP 4.2 ± 1.6* 40 ± 71 11
4.2 (-)-1I/F1-PE 170 ± 50§ 82 ± 9' 14
Control-1I/F1-PE 180 ± 30§ 87 ± 6' 14
Fluorescence photobleaching recovery was used to measure the lateral
mobility of fluorescein labeled glycophorins (GP) and fluorescein-labeled
phosphatidylethanolamine (FI-PE) in intact erythrocytes from one patient
with band 4.2 deficiency and hereditary spherocytosis and one control with
normal erythrocyte morphology. Experiments were performed at 37°C. D,
diffusion coefficient; f, fractional mobility; n, number of measurements.
Values represent mean ± standard deviation. The significance of differ-
ences between means for band 4.2-deficient and control samples was tested
by using Student's unpaired two-tailed t-test (StatView 512+, Abacus
Concepts, Berkeley, CA).
*p = 0.20.
p= 0.27.
p= 0.57.
'p = 0.09.
population. Unexpectedly, there was also a significant in-
crease in the correlation time of the rapidly rotating band 3
population in band 4.2-deficient compared to control cells
(Fig. 2, Table 3). Thus, compared to control erythrocytes,
band 4.2-deficient erythrocytes showed an increased band 3
lateral diffusion coefficient, a shift to the rapidly rotating
band 3 population, an increase in the rotational correlation
time of the rapidly rotating band 3 population, and un-
changed fractions of laterally and rotationally immobile
band 3. We hypothesized that band 3 is both less con-
0.33-r
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FIGURE 2 Typical polarized fluorescence depletion curves showing the
rotational mobility of band 3 in intact erythrocytes from patients with band
4.2 deficiency (HS, lower curve) and controls (Control, upper curve). Data
from approximately 300 cells were collected to obtain each curve. Band
4.2-deficient erythrocytes showed a shift of the band 3 population from the
slowly rotating to the rapidly rotating fraction, indicating increased free-
dom of band 3 rotational movement. Band 4.2 deficiency, a = 46%, Tj =
296 pis, 3 = 52%, T2 = 2.3 ms, r(oo) = 2%. Control, a = 27%, T, = 203
,us, (3 = 64%, T2 = 2.4 ms, r(oo) = 9%.
TABLE 3 Rotational mobility of band 3 in band 4.2-deficient
and control erythrocytes
a T3 r(o)
Sample (%) (,s) (%) (ms) (%) n
4.2 (-)-I 44±4 281 ±22 55±4 2.4±0.2 2±0 2
4.2 (-)-2 36 247 52 1.6 12 1
4.2 (-)-mean 41 ± 5* 269 ± 25t 54 ± 3§ 2.2 ± 0.5w 5 ± 611 3
Control-i 26±1 162±59 59±7 2.0±0.5 15±7 2
Control-2 21 50 72 1.9 7 1
Control-mean 24 ± 3* 124 ± 772 63 ± 9§ 2.0 ± 0.4' 12 ± 811 3
Polarized fluorescence depletion was used to measure the rotational mo-
bility of eosin-labeled band 3 in intact erythrocytes from two patients with
band 4.2 deficiency and hereditary spherocytosis and two controls with
normal erythrocyte morphology. Experiments were performed at 37°C. For
each sample approximately 300 erythrocytes were illuminated by the laser
beam, so the data represented the average rotational mobility of approxi-
mately 3 x 108 band 3 molecules per sample. Rotational mobility param-
eters were determined by nonlinear least-squares analysis, as described in
Materials and Methods. x2 values ranged from 0.10 to 0.59 for the
equations corresponding to the best-fit curves. ca and 3, fractions of band
3 molecules rotating with correlation times T, and T2, respectively. r(oo),
fraction of rotationally immobile band 3 molecules. n, number of samples.
The significance of differences between means for band 4.2-deficient and
control samples was tested by using Student's unpaired two-tailed t-test
(StatView 512+, Abacus Concepts, Berkeley, CA). Values for control
erythrocytes were statistically identical to results in a population of ap-
proximately 25 control individuals (see Corbett and Golan, 1993; Corbett
et al., 1994).
p = 0.0079.
p = 0.036.
§p = 0.15.
lp = 0.67.
'p = 0.27.
strained in its lateral and rotational mobility, due to removal
of low-affinity binding sites, and more highly oligomerized,
due to preferential loss of "free" band 3 dimers, in band
4.2-deficient erythrocytes. We tested this hypothesis further
by measuring the band 3 content of control and band 4.2-
deficient membranes.
Biochemical analysis of band
4.2-deficient erythrocytes
Coomassie blue-stained SDS gels (Fig. 3) were examined
by scanning densitometry. Compared to controls, the band
3/spectrin ratio in ghost membranes of cells from the two
patients with band 4.2 deficiency was reduced by 18% and
14%, respectively. Similar results have been reported pre-
viously (Yawata, 1994). This reproducible finding sug-
gested that, in the absence of band 4.2, a fraction of the band
3 population was lost from cells either during erythroid
development in the bone marrow or during the circulation of
mature erythrocytes. We hypothesized that this loss of band
3 protein, like the changes in band 3 lateral and rotational
mobility, could be due to a reduction, in band 4.2-deficient
erythrocytes, in low-affinity interactions between band 3
and the membrane skeleton. We tested this hypothesis fur-
ther by measuring the extraction of band 3 by Triton X-100
from control and band 4.2-deficient membranes.
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FIGURE 3 Coomassie blue-stained SDS-polyacrylamide gels of ghost
membranes prepared from band 4.2-deficient and control erythrocytes.
Membranes were solubilized in gel sample buffer containing 4% SDS and
electrophoresed on 9% acrylamide gels. (A, B) Matched samples of control
(A) and band 4.2 Nippon (B; Ata et al., 1989) erythrocytes. (C, D) Matched
samples of control (C) and band 4.2 Tozeur (D; Ghanem et al., 1990)
erythrocytes. In lane D, the faint band appearing to comigrate with band 4.2
failed to react with anti-band 4.2 antibodies (data not shown). Compared to
controls, band 4.2-deficient membranes had a 14-18% decrease in the
band 3/spectrin ratio.
Band 3 extractability
Treatment of ghost membranes with Triton X-100 removes
the bulk of membrane lipids and integral membrane pro-
teins, leaving behind a sedimentable membrane skeletal
complex consisting of spectrin, actin, band 4.1, and skele-
ton-associated band 3 (Yu et al., 1973). Membrane skele-
tons were prepared from control and band 4.2-deficient
erythrocytes at two different salt concentrations and three
different concentrations of Triton X-100. From previous
studies it was expected that only band 3 molecules that were
either unattached or bound with low affinity to the skeleton
would be extracted under low-salt conditions, and that most
or all band 3 molecules, including those bound with high
affinity to ankyrin, would be extracted under high-salt con-
ditions (Yu et al., 1973). As shown in Fig. 4, skeletons from
band 4.2-deficient cells retained a greater fraction of band 3
protein than did skeletons from control cells after low-salt
(0 mM NaCl) extraction. In contrast, equal fractions of band
3 protein were retained in skeletons from control and band
4.2-deficient cells after high-salt (150 mM NaCl) extraction
(Fig. 4). These results were consistent with the hypothesis
that band 4.2-deficient erythrocytes are depleted specifi-
cally of band 3 molecules that are either unattached or
bound with low affinity to the membrane skeleton.
Association of band 4.2 with spectrin
We next tested the hypothesis that band 4.2 affects band 3
mobility and skeletal retention through a direct binding
interaction between band 4.2 and spectrin. We first used an
immunoprecipitation binding assay to determine whether
band 4.2 and spectrin could associate in solution. As shown
FIGURE 4 Triton X-100 extraction of band 3 from ghost membranes.
Erythrocyte ghosts were treated with the indicated concentrations of Triton
X-100 in the presence or absence of 150 mM NaCl. The amounts of band
3 retained in the membrane skeletal pellet were quantitated as described in
Materials and Methods. Band 3 content was normalized to the sum of
spectrin plus ankyrin because these proteins comigrated in the gel system
used. Filled symbols, control membranes; open symbols, band 4.2-defi-
cient membranes.
in Fig. 5, spectrin bound to soluble band 4.2 in an apparently
saturable manner. The Scatchard plot of the binding data
was concave (Fig. 5, inset), suggesting either negative co-
operativity or multiple classes of binding sites. The data
could be fitted by nonlinear regression analysis to a model
incorporating two independent classes of binding sites: 1) a
high-affinity (Kd = 7.4 ± 0.2 X 10-9 M-1, mean ± SD),
low-capacity (0.6 0.8 X 10-9 M/liter) class of sites; and
2) a low-affinity (Kd = 2.8 + 2.0 X l0-7 M-1), high-
capacity (5.8 ± 1.0 X 10-9 M/liter) class of sites. The total
5
6
E
c
0
0
N
4
3
2
1
0
0 1 2 3
1251-spectrin free, Mxl0-7
4
FIGURE 5 Binding of 125I-spectrin to band 4.2 in solution. Binding of
normal spectrin to normal band 4.2 was assayed as described in Materials
and Methods. Spectrin was iodinated to a specific activity of 2840 cpm/,ug.
The inset shows a Scatchard plot of the data, which were fitted to a
two-component model by using nonlinear regression analysis. The two
binding sites had the following characteristics: Site 1, Kd = 7.4 X 10-9
M-1, capacity = 0.6 X 10-9 Mlliter; Site 2: Kd = 2.8 X 10-7 M-,
capacity = 5.8 x 10-9 M/liter. Control binding experiments showed that
the antiserum immunoprecipitated 4 X 10-8 M '251-band 4.2.
Control
Patient
.0 0.2 0.4 0.6 0.8 1.0
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amount of bound spectrin was then compared with the
amount of 1251-band 4.2 immunoprecipitated under the con-
ditions of the binding experiment. It was calculated that, at
saturation, there was approximately one spectrin binding
site per seven band 4.2 molecules.
To examine further the role of band 4.2 in skeleton-
membrane interactions, we tested the ability of band 4.2 to
promote spectrin binding to pH 11-stripped inside-out ves-
icles. As shown in Fig. 6, pH 11-stripped vesicles (which
contained no ankyrin or other peripheral proteins) bound
between 30 and 50 ,ug spectrin/mg vesicle protein. Recon-
stituting the vesicles with purified band 4.2 increased spec-
trin binding, at the three concentrations of spectrin tested, to
within 50-80% of the capacity of inside-out vesicles
(which contained normal amounts of ankyrin, band 4.2, and
other membrane-associated proteins). It should be noted
that the contribution of band 4.2 to the spectrin-binding
capacity of the alkaline-stripped vesicles was accentuated in
this experiment, because the membrane content of band 4.2
in vesicles reconstituted with band 4.2 was considerably
greater than that of normal inside-out vesicles. In reconsti-
tuted vesicles the band 4.21band 3 ratio was 0.45, whereas in
normal inside-out vesicles the ratio was 0.15.
DISCUSSION
Constraints on band 3 lateral mobility in normal erythrocyte
membranes include high-affinity binding interactions, low-
affinity binding interactions, and steric hindrance interac-
tions (Corbett and Golan, 1993; Fowler and Bennett, 1978;
Golan and Veatch, 1980; Liu et al., 1990; Mohandas et al.,
1992; Schindler et al., 1980; Tsuji et al., 1988; Tsuji and
Ohnishi, 1986). High-affinity interactions between band 3
FIGURE 6 Binding of '2sI-spectrin
to band 4.2 reconstituted membranes.
pH 11-stripped membranes were pre-
pared and reconstituted with purified
band 4.2 as described in Materials and
Methods. Binding of '251I-spectrin
(specific activity 12,096 cpm/,lg) to
membranes was corrected for nonspe-
cific binding as described in Materials
and Methods. The band 4.2/band 3
ratios on the membranes, determined
by densitometry of Coomassie blue-
stained SDS gels, were pH l-stripped
membranes, 0.02; inside-out vesicles,
0.15; band 4.2 reconstituted inside-out
vesicles, 0.45. Data presented in this
figure were representative of those ob-
tained in five independent experiments
using different preparations of spec-
trin, band 4.2, and membranes.
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tetramers and ankyrin laterally immobilize approximately
40% of band 3 molecules in the normal erythrocyte mem-
brane. Steric hindrance and low-affinity interactions be-
tween band 3 oligomers and the spectrin-based membrane
skeleton slow the rate of lateral diffusion of mobile band 3
molecules by approximately 50-fold compared to the pre-
dicted diffusion rate of "free" band 3 in membranes devoid
of a functional membrane skeleton (Corbett et al., 1994).
Neither high-affinity binding of the cytoplasmic domain of
band 3 to ankyrin nor the state of oligomerization of
ankyrin-linked band 3 complexes appears to be altered in
band 4.2-deficient erythrocytes, because the laterally immo-
bile fraction of band 3 is similar in band 4.2-deficient and
control cells. Although previous studies have shown that
increased spectrin/band 3 ratios are associated with slowing
of band 3 lateral diffusion (Corbett et al., 1994), the band 3
lateral diffusion rate is increased in band 4.2-deficient eryth-
rocytes. Therefore, the increase in the band 3 lateral diffu-
sion coefficient suggests that low-affinity binding interac-
tions are significantly perturbed in band 4.2-deficient
erythrocytes. Because normal band 4.2 binds to the cyto-
plasmic domain of band 3 (Korsgren and Cohen, 1986,
1988), it is likely that the absence of band 4.2 results
directly in a decreased number of low-affinity binding sites
for band 3 on the membrane skeleton.
Band 3 rotational mobility is constrained in normal eryth-
rocytes by high-affinity and low-affinity binding interac-
tions (Clague et al., 1989; Corbett and Golan, 1993; Liu et
al., 1995; Matayoshi and Jovin, 1991; Nigg and Cherry,
1979, 1980; Tilley et al., 1991; Tsuji et al., 1988). In normal
erythrocytes, the rotationally immobile fraction appears to
consist of band 3 molecules bound with high affinity to
ankyrin. The rapidly rotating band 3 population represents
100 200 250
1251-spectrin added, pglml
EJIpH 1 1-stripped
I.O. vesicles
m\\\\] pH 11-stripped 1.O. vesicles
reconstituted with band 4.2
_ I.O. vesicles
Golan et al. 1 539
Volume 70 March 1996
band 3 dimers, tetramers, and higher order oligomers that
are free from constraints other than the viscosity of the lipid
bilayer (Muhiebach and Cherry, 1985). The slowly rotating
band 3 population appears to consist of band 3 oligomers
that are rotationally restricted by low-affinity binding inter-
actions between band 3 and either ankyrin-linked band 3
molecules or any of several membrane skeletal components.
Steric hindrance interactions appear not to play a role in
band 3 rotational mobility restraint (Corbett et al., 1994).
The rotationally immobile fraction of band 3 is similar in
band 4.2-deficient and control erythrocytes, suggesting that
high-affinity binding of band 3 to ankyrin is unperturbed in
band 4.2-deficient cells. Band 4.2-deficient erythrocytes
manifest a significant shift from the slowly to the rapidly
rotating fraction of band 3, consistent with the interpretation
that low-affinity binding sites for band 3 are decreased on
the membrane skeleton of such cells. Band 4.2-deficient
erythrocytes also show a significantly increased rotational
correlation time of the rapidly rotating band 3 fraction.
These data suggest that there is a shift from a lower to a
higher order state of band 3 oligomerization in band 4.2-
deficient erythrocytes. This interpretation is consistent with
the decreases, in band 4.2-deficient erythrocytes, in band
3/spectrin ratio and band 3 extractability, both of which
could be caused by a preferential loss of "free" band 3
dimers from band 4.2-deficient cells. This interpretation is
also consistent with the observed shift, in membranes from
band 4.2-deficient erythrocytes, to a larger average size of
intramembrane particles visualized by freeze fracture elec-
tron microscopy (Yawata, 1994).
At first glance, there appears to be an inconsistency
between our interpretation that "free" band 3 is preferen-
tially lost from band 4.2-deficient erythrocytes and our
finding that the remaining band 3 molecules (which might
have been expected to be more "bound") exhibit increased
rather than decreased lateral and rotational mobility. One
explanation for this apparent inconsistency could be that, in
band 4.2-deficient cells, removal of 250,000 potential low-
affinity band 3 binding sites from the inner surface of the
membrane not only allows preferential loss of band 3 mol-
ecules (probably dimers) that are not attached with high
affinity (either directly or indirectly) to ankyrin, but also
allows more rapid lateral diffusion of the remaining (and
more highly oligomerized) band 3 molecules. We note
further that Triton extractability and band 3 mobility are
likely to be differentially affected by removal of band 4.2.
Triton extractability is governed mainly by the fraction of
band 3 molecules that are bound with high affinity to the
membrane skeleton, whereas the rate of band 3 lateral
mobility is determined mainly by steric and low-affinity
binding interactions between the cytoplasmic domain of
band 3 and the membrane skeleton.
Our interpretation of the present results in terms of an
effect of band 4.2 on band 3 mobility is predicated on the
finding that, in both patients studied (Ata et al., 1989;
Ghanem et al., 1990), the origin of the band 4.2 deficiency
has been traced to a point mutation in the band 4.2 gene. In
one of the patients (band 4.2 Tozeur; Hayette et al., 1995b)
the cDNA encoding the entire cytoplasmic domain of band
3 has been sequenced and shown to be normal, ruling out a
defect in the cytoplasmic domain of band 3. In the other
patient (band 4.2 Nippon; Bouhassira et al., 1992) the lim-
ited tryptic digestion pattern of band 3 in inside-out vesicles
is identical to that of a normal control, suggesting that there
are no major structural abnormalities in the protein (data not
shown).
The present studies suggest that band 4.2 may stabilize
skeleton-membrane interactions by providing a direct link
between band 3 and spectrin. Whereas previous studies have
shown that band 4.2 does not play a direct role in ankyrin
binding (Hargreaves et al., 1980; Korsgren and Cohen,
1988), to our knowledge the involvement of band 4.2 in
spectrin binding has not been addressed. The stoichiometry
of binding in solution (approximately seven band 4.2 mol-
ecules per spectrin dimer) suggests that two band 4.2 tet-
ramers may be required to bind one spectrin dimer. Surpris-
ingly, the Kd of spectrin binding to band 4.2 (2 X 10-7
M-1) is only modestly higher than that for spectrin binding
to ankyrin (between 10-7 and 10-8 M-1; Bennett and
Branton, 1977). The significance of the small number of
high-affinity binding sites remains unclear, but could reflect
the presence of a small pool of band 4.2, which is in a
different physical state (e.g., through altered phosphoryla-
tion or self-association) than the bulk of the protein.
The increased lateral and rotational mobility of band 3 in
band 4.2-deficient erythrocytes could indicate that band 4.2
serves to strengthen the band 3-ankyrin interaction, as has
been suggested in one study (Rybicki et al., 1988). In this
model, the absence of band 4.2 would weaken the band
3-ankyrin interaction and allow increased freedom of band
3 lateral and rotational movement. However, the observa-
tion here that spectrin interacts with band 4.2, together with
previous observations that band 4.2 interacts with band 3
(reviewed in Cohen et al., 1993), suggests a more direct
model in which the absence of band 4.2 leads to increased
band 3 lateral and rotational mobility. Furthermore, it ap-
pears from our data that the amount of band 3 bound to the
membrane skeleton with high affinity is the same in control
and band 4.2-deficient erythrocytes, because the laterally
and rotationally immobile fractions of band 3 molecules and
the extractability of band 3 under high-salt conditions are
identical in these two samples. Although our model does not
require modification of the band 3-ankyrin interaction in
band 4.2-deficient erythrocytes, the present data do not rule
out such an effect.
Our results show that band 4.2 binds spectrin in solution
and promotes spectrin binding to membranes. The absence
of band 4.2 does not appear to result in spectrin deficiency,
however, because the band 3/spectrin ratio in membranes
from band 4.2-deficient erythrocytes is less than that in
normal controls. This observation suggests that band 4.2
deficiency acts primarily to destabilize a fraction of band 3
molecules, resulting in loss of band 3 and possibly of
membrane, rather than to destabilize the membrane skeletal
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network itself. Thus, although band 4.2 is neither a classical
membrane skeletal nor an integral membrane protein, it
appears to promote interactions between these two classes
of membrane proteins.
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